Frequency Therapeutics to Present at the 42nd Annual Mid-Winter Meeting of the Association for Research in Otolaryngology
WOBURN, Mass.--(BUSINESS WIRE)--Feb 7, 2019--Frequency Therapeutics, a clinical-stage biotechnology company creating a new class of drugs based on small molecule stimulation of dor…